8.98
price down icon0.99%   -0.09
after-market アフターアワーズ: 9.15 0.17 +1.89%
loading
前日終値:
$9.07
開ける:
$9.02
24時間の取引高:
374.25K
Relative Volume:
1.09
時価総額:
$294.53M
収益:
$65.42M
当期純損益:
$-32.96M
株価収益率:
-7.0709
EPS:
-1.27
ネットキャッシュフロー:
$-19.87M
1週間 パフォーマンス:
-0.88%
1か月 パフォーマンス:
-15.04%
6か月 パフォーマンス:
-38.85%
1年 パフォーマンス:
+10.59%
1日の値動き範囲:
Value
$8.79
$9.125
1週間の範囲:
Value
$8.79
$9.61
52週間の値動き範囲:
Value
$5.45
$18.98

Neuropace Inc Stock (NPCE) Company Profile

Name
名前
Neuropace Inc
Name
セクター
Healthcare (1164)
Name
電話
(650) 237-2700
Name
住所
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Name
職員
195
Name
Twitter
Name
次回の収益日
2025-03-04
Name
最新のSEC提出書
Name
NPCE's Discussions on Twitter

NPCE を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
NPCE
Neuropace Inc
8.98 297.48M 65.42M -32.96M -19.87M -1.27
Medical Devices icon
ABT
Abbott Laboratories
126.54 218.59B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.14 157.13B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
403.53 151.59B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.94 118.29B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
80.00 44.46B 5.54B 4.18B 623.10M 7.00

Neuropace Inc Stock (NPCE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-28 開始されました H.C. Wainwright Buy
2025-01-21 開始されました UBS Buy
2024-03-14 アップグレード Wells Fargo Equal Weight → Overweight
2024-01-30 開始されました Leerink Partners Outperform
2023-11-10 開始されました Cantor Fitzgerald Overweight
2023-08-24 アップグレード Morgan Stanley Underweight → Equal-Weight
2023-02-22 開始されました Lake Street Buy
2022-04-06 開始されました Wolfe Research Outperform
2022-01-19 ダウングレード Wells Fargo Overweight → Equal Weight
2022-01-07 ダウングレード Morgan Stanley Equal-Weight → Underweight
2021-11-11 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-08-18 開始されました Robert W. Baird Outperform
2021-05-17 開始されました JP Morgan Overweight
2021-05-17 開始されました Morgan Stanley Overweight
2021-05-17 開始されました SVB Leerink Outperform
2021-05-17 開始されました Wells Fargo Overweight
すべてを表示

Neuropace Inc (NPCE) 最新ニュース

pulisher
01:23 AM

NeuroPace Inc. Stock Analysis and ForecastOutstanding risk-reward balance - PrintWeekIndia

01:23 AM
pulisher
08:08 AM

Is NeuroPace Inc. a good long term investmentTremendous growth opportunities - Autocar Professional

08:08 AM
pulisher
02:25 AM

What analysts say about NeuroPace Inc. stockExceptional financial outcomes - PrintWeekIndia

02:25 AM
pulisher
Jul 24, 2025

What drives NeuroPace Inc. stock priceFree Trading Strategy Suggestions - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 19, 2025

NeuroPace, Inc. (NPCE) Backed by Cantor Fitzgerald Following Physician Survey - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

NeuroPace secures $75M credit facility with MidCap Financial - MSN

Jul 18, 2025
pulisher
Jul 17, 2025

(NPCE) Proactive Strategies - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 16, 2025

What makes NeuroPace Inc. stock price move sharplyFree Investing Community - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How NeuroPace Inc. stock performs during market volatilityFree Stock Selection - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why NeuroPace Inc. stock attracts strong analyst attentionFree Stock Market Query - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

NeuroPace appoints Patrick Williams as CFO - MSN

Jul 09, 2025
pulisher
Jul 07, 2025

NeuroPace’s SWOT analysis: innovative epilepsy treatment stock faces growth hurdles By Investing.com - Investing.com South Africa

Jul 07, 2025
pulisher
Jul 06, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, ... - Bluefield Daily Telegraph

Jul 06, 2025
pulisher
Jul 06, 2025

NeuroPace’s SWOT analysis: innovative epilepsy treatment stock faces growth hurdles - Investing.com

Jul 06, 2025
pulisher
Jun 29, 2025

NeuroPaceVolatile, Uncertain, But Promising (NASDAQ:NPCE) - Seeking Alpha

Jun 29, 2025
pulisher
Jun 27, 2025

NeuroPace Inc (NPCE) Trading Down 3.93% on Jun 27 - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc.NPCE - WV News

Jun 27, 2025
pulisher
Jun 26, 2025

NeuroPace stock maintains outperform rating at Leerink on expansion outlook - Investing.com

Jun 26, 2025
pulisher
Jun 25, 2025

NeuroPace stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com UK

Jun 25, 2025
pulisher
Jun 24, 2025

NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm - WV News

Jun 24, 2025
pulisher
Jun 24, 2025

NeuroPace's NAUTILUS Fallout: A Shareholder's Guide to Fraud Claims and Recovery - AInvest

Jun 24, 2025
pulisher
Jun 19, 2025

Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load? - simplywall.st

Jun 19, 2025
pulisher
Jun 16, 2025

Metric Analysis: NeuroPace Inc (NPCE)’s Key Ratios in the Limelight - DWinneX

Jun 16, 2025
pulisher
Jun 16, 2025

10 Best NASDAQ Stocks Under $50 to Buy - Insider Monkey

Jun 16, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Invests $293,000 in NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat

Jun 14, 2025

Neuropace Inc (NPCE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$290.22
price up icon 1.27%
medical_devices STE
$230.46
price up icon 1.41%
medical_devices PHG
$26.16
price up icon 1.24%
$88.99
price up icon 2.59%
$77.61
price up icon 1.09%
medical_devices EW
$80.00
price up icon 5.54%
大文字化:     |  ボリューム (24 時間):